The top line results look pretty good but didn't they have safety issues in the past? And the gout flares in the higher dose groups seems odd to me but maybe its too small an n?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.